Amsterdam, The Netherlands, and Holzgerlingen, Germany, July 01, 2020, 08:30 am CEST - Curetis N.V. in liquidatie (the "Company") today announced the publication of its audited 2019 full year financial results and 2019 Annual Report. Originally scheduled for April 30, 2020, this was delayed due to the impact of the COVID-19 pandemic on the Company’s finance department’s operations, its external advisors, including a purely remote and off-site auditing effort required as part of the liquidation of the Company.

The publication of the audited 2019 full year financial results and 2019 Annual Report follows the delisting from Euronext Amsterdam and Brussels on May 6, 2020, and the Distribution in Advance on May 7, 2020, to the Company’s shareholders holding shares in the Company on the Distribution Record Date on May 6, 2020 of 1,622,568 shares of OpGen Inc., a Delaware corporation.

For a copy of the Annual Report and audited full year 2019 financial statements and more information about the Distribution in Advance, the transaction with OpGen and the delisting of the Company’s shares from Euronext Amsterdam and Euronext Brussels, the Company kindly refers to the Shareholder Circular and the extraordinary general meeting, held on March 10, 2020 and the press release issued by the Company on April 20, 2020, which all are available on the Company’s website at: www.curetis-nv.com.                                                                                                                                                                      ###

Legal Disclaimer This document constitutes neither an offer to buy nor an offer to subscribe for securities and neither this document nor any part of it should form the basis of any investment decision in Curetis.The information contained in this press release has been carefully prepared. However, Curetis bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. Curetis does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons.

This press release includes statements that are, or may be deemed to be, “forward-looking statements.” These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “intends,” “targets,” “may,” “will,” or “should” and include statements Curetis makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Curetis’ actual results may differ materially from those predicted by the forward-looking statements. Curetis undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

Contact detailsCuretis N.V. in liquidatie Max-Eyth-Str. 42 71088 Holzgerlingen, Germany Tel. +49 7031 49195-10 www.curetis-nv.com  

Attachment

  • 20200630_Curetis_NV_PR_AR2019_Published-V2-CLEAN
Direxion Daily Healthcar... (AMEX:CURE)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Direxion Daily Healthcar...
Direxion Daily Healthcar... (AMEX:CURE)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Direxion Daily Healthcar...